Oragenics Inc (NYSEAMERICAN: OGEN) Major News Alert! OGEN Reaches Final Steps of Manufacturing ONP-002, for Phase II Clinical Trial Combined with its Intranasal Device for Treatment of mild Traumatic Brain Injury / Concussion
Oragenics Inc (NYSEAMERICAN: OGEN) – is a volatile biotech that should be at the top of investors’ watch lists as the stock moves steadily northbound off its recent lows. OGEN…